| 摘要 |
<p>A method for treating or preventing bronchoconstriction or reversible pulmonary vasoconstriction in a mammal, which method includes causing the mammal to inhale a therapeutically-effective concentration of gaseous nitric oxide (1,10) or a therapeutically-effective amount of a nitric oxide-releasing compound (106), and an inhaler device (102) containing nitric oxide gas and/or a nitric oxide-releasing compound. <IMAGE></p> |
